A detailed history of Black Rock Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 21,225,119 shares of IOVA stock, worth $182 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,225,119
Previous 19,929,702 6.5%
Holding current value
$182 Million
Previous $295 Million 42.37%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$7.78 - $14.19 $10.1 Million - $18.4 Million
1,295,417 Added 6.5%
21,225,119 $170 Million
Q1 2024

May 10, 2024

BUY
$7.59 - $17.47 $6.51 Million - $15 Million
857,946 Added 4.5%
19,929,702 $295 Million
Q4 2023

Feb 13, 2024

BUY
$3.3 - $8.89 $2.29 Million - $6.18 Million
695,327 Added 3.78%
19,071,756 $155 Million
Q3 2023

Nov 13, 2023

BUY
$4.44 - $8.79 $6.1 Million - $12.1 Million
1,374,638 Added 8.09%
18,376,429 $83.6 Million
Q2 2023

Aug 11, 2023

BUY
$5.36 - $9.06 $24.4 Million - $41.2 Million
4,545,129 Added 36.49%
17,001,791 $120 Million
Q1 2023

May 12, 2023

BUY
$5.53 - $8.22 $2.1 Million - $3.12 Million
379,560 Added 3.14%
12,456,662 $76.1 Million
Q4 2022

Feb 13, 2023

BUY
$5.62 - $10.0 $3.43 Million - $6.11 Million
610,610 Added 5.33%
12,077,102 $77.2 Million
Q3 2022

Nov 14, 2022

SELL
$9.53 - $13.11 $996,590 - $1.37 Million
-104,574 Reduced 0.9%
11,466,492 $110 Million
Q2 2022

Aug 12, 2022

BUY
$6.38 - $18.33 $26.4 Million - $75.9 Million
4,142,074 Added 55.76%
11,571,066 $128 Million
Q1 2022

May 12, 2022

BUY
$12.38 - $19.1 $253,629 - $391,301
20,487 Added 0.28%
7,428,992 $124 Million
Q4 2021

Feb 10, 2022

BUY
$16.55 - $27.63 $7.62 Million - $12.7 Million
460,699 Added 6.63%
7,408,505 $141 Million
Q3 2021

Nov 09, 2021

BUY
$20.35 - $26.63 $3.66 Million - $4.78 Million
179,637 Added 2.65%
6,947,806 $171 Million
Q2 2021

Aug 11, 2021

BUY
$16.33 - $33.07 $111 Million - $224 Million
6,768,169 New
6,768,169 $176 Million

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.36B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.